Literature DB >> 28331021

Aspergillus niger infection in an immunosuppressed patient confined solely to the brain.

Lucy Simmonds1, Sian Mitchell1, Barrie White1, Shanika A Crusz2, David Denning3.   

Abstract

A 68-year-old woman with a background of hypertension, stroke and rheumatoid arthritis presented to her local hospital after a 4-week history of gradual deterioration and increasing confusion with new onset right-sided weakness. Her initial CT scan revealed a rim enhancing mass lesion with surrounding oedema in the left parietal lobe for which she underwent CT stealth-guided biopsy. Microbiology culture of the 2 biopsy samples yielded Aspergillus niger and she was started on the antifungal agent voriconazole. MRI 2 weeks after the procedure also demonstrated radiological findings consistent with intracranial aspergillosis. She later developed leucopenia with neutrophils of 1.5×109/L and her methotrexate and voriconazole were stopped. Voriconazole was changed to oral posaconazole. She did not undergo surgical resection and has continued to improve clinically on posaconazole, with recovery in her white cell count. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28331021      PMCID: PMC5372240          DOI: 10.1136/bcr-2016-218658

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  1 in total

1.  The potency of luliconazole against clinical and environmental Aspergillus nigri complex.

Authors:  Sahar Hivary; Mahnaz Fatahinia; Marzieh Halvaeezadeh; Ali Zarei Mahmoudabadi
Journal:  Iran J Microbiol       Date:  2019-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.